-
2
-
-
62649094499
-
Screening, surveillance, and prevention for esophageal cancer
-
Tomizawa Y, Wang K K. Screening, surveillance, and prevention for esophageal cancer. Gastroenterol Clin North Am 2009, 38:viii-73.
-
(2009)
Gastroenterol Clin North Am
, vol.38
-
-
Tomizawa, Y.1
Wang, K.K.2
-
3
-
-
39449136419
-
Abdominal obesity and the risk of esophageal and gastric cardia carcinomas
-
Corley D A, Kubo A, Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev 2008, 17:352-8.
-
(2008)
Cancer Epidemiol Biomarkers Prev
, vol.17
, pp. 352-358
-
-
Corley, D.A.1
Kubo, A.2
Zhao, W.3
-
4
-
-
31644446784
-
Airborne occupational exposures and risk of oesophageal and cardia adenocarcinoma
-
Jansson C, Plato N, Johansson A L, Nyren O, Lagergren J. Airborne occupational exposures and risk of oesophageal and cardia adenocarcinoma. Occup Environ Med 2006, 63:107-12.
-
(2006)
Occup Environ Med
, vol.63
, pp. 107-112
-
-
Jansson, C.1
Plato, N.2
Johansson, A.L.3
Nyren, O.4
Lagergren, J.5
-
5
-
-
23444453258
-
Occupational exposures and risk of esophageal and gastric cardia cancers among male Swedish construction workers
-
Jansson C, Johansson A L, Bergdahl I A. Occupational exposures and risk of esophageal and gastric cardia cancers among male Swedish construction workers. Cancer Causes Control 2005, 16:755-64.
-
(2005)
Cancer Causes Control
, vol.16
, pp. 755-764
-
-
Jansson, C.1
Johansson, A.L.2
Bergdahl, I.A.3
et al4
-
6
-
-
37849189880
-
Molecular biologic staging of esophageal cancer
-
D'Amico T A. Molecular biologic staging of esophageal cancer. Thorac Surg Clin 2006, 16:317-27.
-
(2006)
Thorac Surg Clin
, vol.16
, pp. 317-327
-
-
D'Amico, T.A.1
-
7
-
-
28844456547
-
The molecular biology of esophageal adenocarcinoma
-
Koppert L B, Wijnhoven B P, van Dekken H, Tilanus H W, Dinjens W N. The molecular biology of esophageal adenocarcinoma. J Surg Oncol 2005, 92:169-90.
-
(2005)
J Surg Oncol
, vol.92
, pp. 169-190
-
-
Koppert, L.B.1
Wijnhoven, B.P.2
van Dekken, H.3
Tilanus, H.W.4
Dinjens, W.N.5
-
8
-
-
0035300727
-
Methylation of p15 and p16 genes in acute promyelocytic leukemia: potential diagnostic and prognostic significance
-
Chim C S, Liang R, Tam C Y, Kwong Y L. Methylation of p15 and p16 genes in acute promyelocytic leukemia: potential diagnostic and prognostic significance. J Clin Oncol 2001, 19:2033-40.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2033-2040
-
-
Chim, C.S.1
Liang, R.2
Tam, C.Y.3
Kwong, Y.L.4
-
9
-
-
33646871766
-
Methylation of CpG islands of p16 associated with progression of primary gastric carcinomas
-
Luo D, Zhang B, Lv L. Methylation of CpG islands of p16 associated with progression of primary gastric carcinomas. Lab Invest 2006, 86:591-8.
-
(2006)
Lab Invest
, vol.86
, pp. 591-598
-
-
Luo, D.1
Zhang, B.2
Lv, L.3
et al4
-
10
-
-
0027769876
-
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
-
Serrano M, Hannon G J, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993, 366:704-7.
-
(1993)
Nature
, vol.366
, pp. 704-707
-
-
Serrano, M.1
Hannon, G.J.2
Beach, D.3
-
11
-
-
0029011539
-
5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers
-
Merlo A, Herman J G, Mao L. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995, 1:686-92.
-
(1995)
Nat Med
, vol.1
, pp. 686-692
-
-
Merlo, A.1
Herman, J.G.2
Mao, L.3
et al4
-
12
-
-
0028875205
-
Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing
-
Gonzalez-Zulueta M, Bender C M, Yang A S. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 1995, 55:4531-5.
-
(1995)
Cancer Res
, vol.55
, pp. 4531-4535
-
-
Gonzalez-Zulueta, M.1
Bender, C.M.2
Yang, A.S.3
et al4
-
13
-
-
0028845142
-
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
-
Herman J G, Merlo A, Mao L. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995, 55:4525-30.
-
(1995)
Cancer Res
, vol.55
, pp. 4525-4530
-
-
Herman, J.G.1
Merlo, A.2
Mao, L.3
et al4
-
14
-
-
12444268993
-
Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma
-
Brock M V, Gou M, Akiyama Y. Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin Cancer Res 2003, 9:2912-9.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 2912-2919
-
-
Brock, M.V.1
Gou, M.2
Akiyama, Y.3
et al4
-
15
-
-
0034796682
-
Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma
-
Hibi K, Taguchi M, Nakayama H. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin Cancer Res 2001, 7:3135-8.
-
(2001)
Clin Cancer Res
, vol.7
, pp. 3135-3138
-
-
Hibi, K.1
Taguchi, M.2
Nakayama, H.3
et al4
-
16
-
-
26644457414
-
Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma
-
Abbaszadegan M R, Raziee H R, Ghafarzadegan K, Shakeri M T, Afsharnezhad S, Ghavamnasiry M R. Aberrant p16 methylation, a possible epigenetic risk factor in familial esophageal squamous cell carcinoma. Int J Gastrointest Cancer 2005, 36:47-54.
-
(2005)
Int J Gastrointest Cancer
, vol.36
, pp. 47-54
-
-
Abbaszadegan, M.R.1
Raziee, H.R.2
Ghafarzadegan, K.3
Shakeri, M.T.4
Afsharnezhad, S.5
Ghavamnasiry, M.R.6
-
17
-
-
60549105721
-
Qualitative analysis of adenomatous polyposis coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker
-
Zare M, Jazii F R, Alivand M R, Nasseri N K, Malekzadeh R, Yazdanbod M. Qualitative analysis of adenomatous polyposis coli promoter: hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker. BMC Cancer 2009, 9:24.
-
(2009)
BMC Cancer
, vol.9
, pp. 24
-
-
Zare, M.1
Jazii, F.R.2
Alivand, M.R.3
Nasseri, N.K.4
Malekzadeh, R.5
Yazdanbod, M.6
-
18
-
-
33646107147
-
Does the TNM staging system for esophageal cancer need revision?
-
author reply 856
-
Pramesh C S, Mistry R C, Jambhekar N A, Laskar S G. Does the TNM staging system for esophageal cancer need revision? J Am Coll Surg 2006, 202:855-6. author reply 856
-
(2006)
J Am Coll Surg
, vol.202
, pp. 855-856
-
-
Pramesh, C.S.1
Mistry, R.C.2
Jambhekar, N.A.3
Laskar, S.G.4
-
19
-
-
58149288422
-
Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens
-
Thompson S K, Ruszkiewicz A R, Jamieson G G. Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens. Ann Surg Oncol 2008, 15:3447-58.
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 3447-3458
-
-
Thompson, S.K.1
Ruszkiewicz, A.R.2
Jamieson, G.G.3
et al4
-
20
-
-
11144355566
-
Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood
-
Sabbioni S, Miotto E, Veronese A. Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood. Mol Diagn 2003, 7:201-7.
-
(2003)
Mol Diagn
, vol.7
, pp. 201-207
-
-
Sabbioni, S.1
Miotto, E.2
Veronese, A.3
et al4
-
21
-
-
0033563083
-
CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression
-
Eads C A, Danenberg K D, Kawakami K, Saltz L B, Danenberg P V, Laird P W. CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res 1999, 59:2302-6.
-
(1999)
Cancer Res
, vol.59
, pp. 2302-2306
-
-
Eads, C.A.1
Danenberg, K.D.2
Kawakami, K.3
Saltz, L.B.4
Danenberg, P.V.5
Laird, P.W.6
-
22
-
-
3142663169
-
Hypermethylation of tumor suppressor genes (p16INK4A, p14ARF and APC) in adenocarcinomas of the upper gastrointestinal tract
-
Sarbia M, Geddert H, Klump B, Kiel S, Iskender E, Gabbert H E. Hypermethylation of tumor suppressor genes (p16INK4A, p14ARF and APC) in adenocarcinomas of the upper gastrointestinal tract. Int J Cancer 2004, 111:224-8.
-
(2004)
Int J Cancer
, vol.111
, pp. 224-228
-
-
Sarbia, M.1
Geddert, H.2
Klump, B.3
Kiel, S.4
Iskender, E.5
Gabbert, H.E.6
-
23
-
-
0032589744
-
Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma
-
Xing E P, Nie Y, Song Y. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Clin Cancer Res 1999, 5:2704-13.
-
(1999)
Clin Cancer Res
, vol.5
, pp. 2704-2713
-
-
Xing, E.P.1
Nie, Y.2
Song, Y.3
et al4
-
24
-
-
0036210281
-
P16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus
-
Bian Y S, Osterheld M C, Fontolliet C, Bosman F T, Benhattar J. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus. Gastroenterology 2002, 122:1113-21.
-
(2002)
Gastroenterology
, vol.122
, pp. 1113-1121
-
-
Bian, Y.S.1
Osterheld, M.C.2
Fontolliet, C.3
Bosman, F.T.4
Benhattar, J.5
-
25
-
-
0036799084
-
Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma
-
Nie Y, Liao J, Zhao X. Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma. Carcinogenesis 2002, 23:1713-20.
-
(2002)
Carcinogenesis
, vol.23
, pp. 1713-1720
-
-
Nie, Y.1
Liao, J.2
Zhao, X.3
et al4
-
26
-
-
34248346381
-
A 26-year cohort mortality study of French construction workers aged 20-64 years
-
Thuret A, Geoffroy-Perez B, Luce D, Goldberg M, Imbernon E. A 26-year cohort mortality study of French construction workers aged 20-64 years. J Occup Environ Med 2007, 49:546-56.
-
(2007)
J Occup Environ Med
, vol.49
, pp. 546-556
-
-
Thuret, A.1
Geoffroy-Perez, B.2
Luce, D.3
Goldberg, M.4
Imbernon, E.5
-
27
-
-
23044493202
-
Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications
-
Hampel H, Abraham N S, El-Serag H B. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005, 143:199-211.
-
(2005)
Ann Intern Med
, vol.143
, pp. 199-211
-
-
Hampel, H.1
Abraham, N.S.2
El-Serag, H.B.3
-
28
-
-
0035254979
-
Overweight as an avoidable cause of cancer in Europe
-
Bergstrom A, Pisani P, Tenet V, Wolk A, Adami H O. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001, 91:421-30.
-
(2001)
Int J Cancer
, vol.91
, pp. 421-430
-
-
Bergstrom, A.1
Pisani, P.2
Tenet, V.3
Wolk, A.4
Adami, H.O.5
-
29
-
-
33845362758
-
Body mass index as a prognostic factor in endometrioid adenocarcinoma of the endometrium
-
Gates E J, Hirschfield L, Matthews R P, Yap O W. Body mass index as a prognostic factor in endometrioid adenocarcinoma of the endometrium. J Natl Med Assoc 2006, 98:1814-22.
-
(2006)
J Natl Med Assoc
, vol.98
, pp. 1814-1822
-
-
Gates, E.J.1
Hirschfield, L.2
Matthews, R.P.3
Yap, O.W.4
-
30
-
-
50249116098
-
The association between obesity and GERD: a review of the epidemiological evidence
-
El-Serag H. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci 2008, 53:2307-12.
-
(2008)
Dig Dis Sci
, vol.53
, pp. 2307-2312
-
-
El-Serag, H.1
-
31
-
-
38849185903
-
Adiposity and age are statistically related to enhanced RASSF1A tumor suppressor gene promoter methylation in normal autopsy kidney tissue
-
Peters I, Vaske B, Albrecht K, Kuczyk M A, Jonas U, Serth J. Adiposity and age are statistically related to enhanced RASSF1A tumor suppressor gene promoter methylation in normal autopsy kidney tissue. Cancer Epidemiol Biomarkers Prev 2007, 16:2526-32.
-
(2007)
Cancer Epidemiol Biomarkers Prev
, vol.16
, pp. 2526-2532
-
-
Peters, I.1
Vaske, B.2
Albrecht, K.3
Kuczyk, M.A.4
Jonas, U.5
Serth, J.6
-
32
-
-
33748528622
-
Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas
-
Ye C, Shrubsole M J, Cai Q. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas. Oncol Rep 2006, 16:429-35.
-
(2006)
Oncol Rep
, vol.16
, pp. 429-435
-
-
Ye, C.1
Shrubsole, M.J.2
Cai, Q.3
et al4
|